Pages that link to "Q30900960"
Jump to navigation
Jump to search
The following pages link to Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice (Q30900960):
Displaying 50 items.
- Evidence for differential effects of apoE3 and apoE4 on HDL metabolism (Q24313446) (← links)
- Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent (Q24628806) (← links)
- Regression of atherosclerosis: insights from animal and clinical studies (Q27028112) (← links)
- Golgi-associated maturation of very low density lipoproteins involves conformational changes in apolipoprotein B, but is not dependent on apolipoprotein E (Q28577984) (← links)
- Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. (Q31452265) (← links)
- The key role of apolipoprotein E in atherosclerosis (Q33213990) (← links)
- ApoE plasma levels and risk of cardiovascular mortality in old age (Q33242076) (← links)
- Apolipoprotein E and coronary disease: a puzzling paradox (Q33244905) (← links)
- An inducible and reversible mouse genetic rescue system (Q33332589) (← links)
- Altered gene expression in early atherosclerosis is blocked by low level apolipoprotein E (Q33344456) (← links)
- Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector (Q33949311) (← links)
- Advances in experimental dyslipidemia and atherosclerosis (Q34368686) (← links)
- Anti-oxidant properties of high-density lipoprotein and atherosclerosis (Q34440172) (← links)
- Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability (Q34443186) (← links)
- Is there a genetic basis for resistance to atherosclerosis? (Q34470216) (← links)
- Recent advances in liver-directed gene therapy for dyslipidemia (Q34586826) (← links)
- Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation (Q35014212) (← links)
- Vascular apolipoprotein e expression and recruitment from circulation to modulate smooth muscle cell response to endothelial denudation (Q35098355) (← links)
- Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging (Q35561963) (← links)
- ApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endothelium (Q35744441) (← links)
- APOE Polymorphism Is Associated with C-reactive Protein Levels but Not with White Blood Cell Count: Dong-gu Study and Namwon Study (Q35778546) (← links)
- Animal models of atherosclerosis (Q35903298) (← links)
- Apolipoprotein E-induced cell signaling in the vessel wall (Q35919265) (← links)
- Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein (Q35974993) (← links)
- Gene Therapy Targeting LDL Cholesterol but not HDL Cholesterol Induces Regression of Advanced Atherosclerosis in a Mouse Model of Familial Hypercholesterolemia (Q36344509) (← links)
- ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice (Q36462065) (← links)
- Influence of PDZK1 on lipoprotein metabolism and atherosclerosis (Q36708971) (← links)
- ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation (Q36804822) (← links)
- ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis (Q36843340) (← links)
- Rapid regression of atherosclerosis: insights from the clinical and experimental literature (Q37068628) (← links)
- Residues Leu261, Trp264, and Phe265 account for apolipoprotein E-induced dyslipidemia and affect the formation of apolipoprotein E-containing high-density lipoprotein. (Q37330045) (← links)
- Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity. (Q37597603) (← links)
- Role of apolipoprotein E genotype in coronary artery disease (Q37608596) (← links)
- Androgen deficiency and atherosclerosis: The lipid link (Q37612176) (← links)
- Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux. (Q38747495) (← links)
- Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis? (Q38888696) (← links)
- The phenomenon of atherosclerosis reversal and regression: Lessons from animal models. (Q39096907) (← links)
- The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor (Q40428631) (← links)
- Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT. (Q41902903) (← links)
- Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall (Q42019558) (← links)
- Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice (Q43806634) (← links)
- Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism (Q43855742) (← links)
- Bone marrow chimerism prevents atherosclerosis in arterial walls of mice deficient in apolipoprotein E. (Q43907946) (← links)
- Transgenic overexpression of human lecithin: cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition (Q44123471) (← links)
- Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia (Q44138790) (← links)
- Enhancement of scavenger receptor class B type I-mediated selective cholesteryl ester uptake from apoA-I(-/-) high density lipoprotein (HDL) by apolipoprotein A-I requires HDL reorganization by lecithin cholesterol acyltransferase (Q44243384) (← links)
- Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A. (Q44511121) (← links)
- Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression (Q44570731) (← links)
- No aggravation of renal injury in apolipoprotein E knockout mice (ApoE(-/-)) after subtotal nephrectomy (Q44758536) (← links)
- Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E. (Q45733720) (← links)